CD70: A NEW TUMOR SPECIFIC BIOMARKER FOR RENAL CELL CARCINOMA
- 1 June 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 173 (6) , 2150-2153
Abstract
Purpose: To date there have been no specific tumor markers available for the differential diagnosis of renal cell carcinoma (RCC). In an earlier study we identified high RNA expression of C...Keywords
This publication has 16 references indexed in Scilit:
- Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial NeoplasmsAmerican Journal of Surgical Pathology, 2002
- CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumorsInternational Journal of Cancer, 2002
- CD70 Expression in Thymic CarcinomaAmerican Journal of Surgical Pathology, 2000
- Aberrant expression and reverse signalling of CD70 on malignant B cellsBritish Journal of Haematology, 1999
- Control of lymphocyte function through CD27–CD70 interactionsSeminars in Immunology, 1998
- Renal cell carcinomaCurrent Opinion in Oncology, 1998
- Increase of Renal Cell Carcinoma Incidence in Central EuropeEuropean Urology, 1998
- Antigen‐presenting cell‐derived signals determine expression levels of CD70 on‘qc primed T cellsImmunology, 1997
- Phenotype and function of human B cells expressing CD70 (CD27 ligand)European Journal of Immunology, 1996
- Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.Journal of Clinical Oncology, 1993